| Dr William Andre' Cenac, MD | |
|
1307 Old Jeanerette Rd, Suite 100, New Iberia, LA 70563-5800 | |
| (337) 364-3000 | |
| (337) 364-5333 |
| Full Name | Dr William Andre' Cenac |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 40 Years |
| Location | 1307 Old Jeanerette Rd, New Iberia, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629175633 | NPI | - | NPPES |
| 1358941 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XX0005X | Orthopaedic Surgery - Sports Medicine | 017658 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Acadian Homecare Of New Iberia, Llc | New iberia, LA | Home health agency |
| Iberia Medical Center | New iberia, LA | Hospital |
| Entity Name | Wm. Andre Cenac, Md Apmc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215332770 PECOS PAC ID: 9830311745 Enrollment ID: O20141110000653 |
News Archive
At ASMS 2016, Bruker announces a new mass spectral library called Bruker MetaboBASE Personal LibraryTM, which contains high-resolution, accurate mass MS/MS spectra of over 13,000 metabolic compounds for the seamless identification of metabolites.
Regulus Therapeutics Inc. announced today that it has obtained exclusive rights from the University of Wuerzburg to intellectual property covering methods for modulating microRNA-21. Regulus scientists and collaborators have shown that microRNA-21, (miR-21), is dysregulated in mouse models of cardiac disease and fibrosis, and that antagonizing miR-21 with therapeutic oligonucleotides targeting miR-21 inhibits fibrosis and attenuates cardiac function in such models. Regulus is currently developing a microRNA therapeutic targeting miR-21 as an anti-fibrotic therapy.
A new study conducted by researchers from the University of Verona and the Institute G. Gaslini in Genova, Italy, confirms the pivotal role played by Cytomegalovirus infection in the pathogenesis of atherosclerosis.
Researchers have shown that a novel delivery strategy can efficiently introduce a functional microRNA that has anti-cancer and angiogenic activities into two different types of cells-breast cancer cells to inhibit tumor growth and metastasis, and cells that line blood vessels to protect against atherosclerosis.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr William Andre' Cenac, MD 1307 Old Jeanerette Rd, Suite 100, New Iberia, LA 70563-5800 Ph: (337) 364-3000 | Dr William Andre' Cenac, MD 1307 Old Jeanerette Rd, Suite 100, New Iberia, LA 70563-5800 Ph: (337) 364-3000 |
News Archive
At ASMS 2016, Bruker announces a new mass spectral library called Bruker MetaboBASE Personal LibraryTM, which contains high-resolution, accurate mass MS/MS spectra of over 13,000 metabolic compounds for the seamless identification of metabolites.
Regulus Therapeutics Inc. announced today that it has obtained exclusive rights from the University of Wuerzburg to intellectual property covering methods for modulating microRNA-21. Regulus scientists and collaborators have shown that microRNA-21, (miR-21), is dysregulated in mouse models of cardiac disease and fibrosis, and that antagonizing miR-21 with therapeutic oligonucleotides targeting miR-21 inhibits fibrosis and attenuates cardiac function in such models. Regulus is currently developing a microRNA therapeutic targeting miR-21 as an anti-fibrotic therapy.
A new study conducted by researchers from the University of Verona and the Institute G. Gaslini in Genova, Italy, confirms the pivotal role played by Cytomegalovirus infection in the pathogenesis of atherosclerosis.
Researchers have shown that a novel delivery strategy can efficiently introduce a functional microRNA that has anti-cancer and angiogenic activities into two different types of cells-breast cancer cells to inhibit tumor growth and metastasis, and cells that line blood vessels to protect against atherosclerosis.
› Verified 3 days ago
Dr. Douglas A Bernard, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 510 Jefferson Terrace Blvd, Suite A, New Iberia, LA 70560 Phone: 337-365-8161 Fax: 337-365-0294 | |
Dr. Harold James Hebert, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 510 Jefferson Terrace Blvd., Suite A, New Iberia, LA 70560 Phone: 337-365-8161 Fax: 337-365-0294 | |
Dr. Edward J Lisecki, M.D., Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 516 Jefferson Ter, Suite 100, New Iberia, LA 70560 Phone: 337-364-5310 Fax: 337-364-5313 | |
Dr. Kyle Allen Caswell, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 516 Jefferson Ter, Suite 100, New Iberia, LA 70560 Phone: 337-364-5310 | |
Dr. John C Osborne, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2308 E Main St Ste C, New Iberia, LA 70560 Phone: 337-369-1434 Fax: 337-369-1436 | |
Dr. Seth Daniel Rosenzweig, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 500 N Lewis St, Suite 280, New Iberia, LA 70563 Phone: 337-367-1444 Fax: 337-367-1445 |